Safety, Tolerance, and Pharmacokinetics of High Doses of Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Contrast Agent
- 1 November 1994
- journal article
- Published by Elsevier in Academic Radiology
- Vol. 1, S2-S9
- https://doi.org/10.1016/s1076-6332(12)80026-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Enhancement of Thoracic Masses using Nonionic MR Contrast AgentsJournal of Computer Assisted Tomography, 1994
- Use of the Magnetic Resonance Contrast Agent Gadodiamide in the Central Nervous System Results of a Multicenter TrialInvestigative Radiology, 1993
- Current Status of Enhanced Magnetic Resonance Imaging in NeuroradiologyInvestigative Radiology, 1993
- Gadodiamide InjectionInvestigative Radiology, 1993
- A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement AgentInvestigative Radiology, 1991
- Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.Radiology, 1990
- Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.Radiology, 1990
- Serum alkaline phosphatase and serum zinc levels in the diagnosis and exclusion of zinc deficiency in manThe American Journal of Clinical Nutrition, 1985
- Characteristics of gadolinium-DTPA complex: a potential NMR contrast agentAmerican Journal of Roentgenology, 1984
- Evaluation of storage iron by chelatesThe American Journal of Medicine, 1968